Substance Regulation and Safety Act Brings Marijuana Closer to Legalization 

Never in modern history has there existed greater public support for ending the nation’s nearly century-long failed experiment with marijuana prohibition. A Democratic senator brought the legalization movement one step closer to reality, sponsoring a new bill to federally legalize marijuana, creating yet another potential avenue through which Congress could enact the policy change. 

 

This piece of legislation, sponsored by Sen. Tina Smith (D-MN), would remove cannabis from the Controlled Substances Act and direct several federal agencies to develop regulations for the plant. 

Titled the “Substance Regulation and Safety Act,” the bill would deschedule cannabis, require the U.S. Department of Health and Human Services (HHS) to develop rules that treat marijuana the same as tobacco and create a national research institute to evaluate the risks and benefits of cannabis. 

 

The descheduling provisions “are retroactive and shall apply to any offense committed, case pending, or conviction entered, and, in the case of a juvenile, any offense committed, case pending, or adjudication of juvenile delinquency entered, before, on, or after the date of the enactment of this Act,” the text of the bill states. 

 

“The federal prohibition on marijuana is a failed policy that contributes to mass incarceration and the racist over-policing of communities of color. It is time to end that policy,” said Sen. Smith. “In addition to addressing the harmful and racist legacy of the War on Drugs by passing bills like Senator Harris’ Marijuana Opportunity Reinvestment and Expungement (MORE) Act, we must address marijuana legalization in a manner that ensures that cannabis and cannabis products are safe, regulated, and well-researched.” 

 

The bill also includes a number of regulations focusing on public safety. The Department of Agriculture would be directed to create a set of quality control standards for cannabis products that would apply to the entire country. The Department of Transportation would be tasked with developing new methods to crack down on stoned drivers, and Customs and Border Protection officials would need to design regulations for safely allowing cannabis imports and exports. 

 

Specifically, the SRSA Act would do the following: 

  • Remove the federal prohibition on marijuana, by taking it off the list of illegal controlled substances from Schedule I of the Controlled Substances Act, especially since 42 states and the District of Columbia already allow marijuana use. 
  • Grant the Food and Drug Administration authority to regulate cannabis and cannabis products, including regarding labeling and advertising standards – just as it does for tobacco products. 
  • Establish 21 years of age as the minimum age for purchasing cannabis products, in line with tobacco and alcohol. 
  • Establish a national strategy to combat the use and abuse of cannabis by youth, with special considerations to prevent racially disparate impacts of the strategy. 
  • Promote the safety and quality control of cannabis crops. 
  • Require regulations to govern the safe import and export of cannabis materials. 
  • Require transportation safety research to establish an evidence-based standard for detecting cannabis-impaired driving, and to ensure that recommended best practices do not contribute to racist enforcement patterns.  

 

“This is the most significant vote on marijuana policy reform that the House of Representatives has taken this year,” said NORML Political Director Justin Strekal. “The importance of this bipartisan vote cannot be overstated as today; nearly one in four Americans reside in a jurisdiction where the adult use of cannabis is legal under state statute. It is time for Congress to acknowledge this reality and retain these protections in the final spending bill.” 

 

“The next logical step for House Leadership is to bring legislation to the floor to end prohibition and demonstrate to the American people that the era of marijuana criminalization is drawing to a close,” Strekal concluded. 

Recent Articles

You’ve chosen to work in a gray area. You sell products that contain cannabis or cannabis-adjacent substances as well as accessories that can be used to consume it. And while that area has become less gray—you can see rays of sunlight peeking through—the skies are still cloudy. THC remains a Schedule 1 substance, even as medical marijuana has migrated to Schedule 3.
Running a cannabis business is notoriously complicated. For dispensaries, complex compliance burdens permeate every facet of the business, from zoning and licensing to marketing and payments. Whether you’ve been in the cannabis space for mere months or multiple decades, you’ve likely run into drawn-out approval processes, supply chain headaches, or constantly changing regulation that makes compliance challenging, not to mention the other micro and macroeconomic factors that plague all small business owners.
Blending traditional values with modernized, energetic branding, Not Ya Son’s Weed falls somewhere between the cannabis days of yore and today’s recreational cannabis boom. Not Ya Son’s Weed offers a variety of products—including pre-rolls, exotic flower, and gummies—that provide much-needed relief without being too overbearing.
The officials came for Lance Alyas once before. In 2023, they caught him in a sting, seized his merchandise, and tossed him in jail. But just seven days later, after he invoked Hawaii's version of a Freedom of Information Act request, the whole case fell apart. Alyas was released without bail, allowed to simply walk out the door. Now, he’s advocating for freedom from Hawaii’s state officials once again. Only this time, it’s not just his own freedom. As the owner of Oahu’s top-rated smoke shops, he’s fighting for everyone’s right to sell hemp products in the Aloha State.
Born Sara Benetowa in Warsaw, Poland, in 1903, Sula Benet may not be an immediately recognizable name in cannabis spaces today, but she should be. While she primarily studied Polish folk customs, Benet became known for her graduate thesis at the University of Warsaw, titled Hashish in Folk Customs and Beliefs. In the paper, she claims that the plant kaneh bosm—which is referenced throughout the Old Testament and Torah and often translated as “calamus”—actually refers to hemp. Benet’s theory remains both significant and highly controversial today, especially as various religious and evangelical groups continue to demonize the plant.
If the United States were ever a country based on strict adherence to the law, those days are long past. The modern game lies in devising methods to circumvent laws. It’s how the rich avoid taxes, the powerful avoid jail, and industries of all kinds bypass regulations. The paradox is that, despite its ubiquity, it’s not easy to stay beyond the reach of the long arm of the law. Well-moneyed, influential organizations still sometimes misjudge the political and legal playing field and have to pay up. The Sacklers (the family behind Purdue Pharma) eventually were bankrupted by the courts for their role in the opioid epidemic, and officials hit Meta with a $5 billion fine over privacy concerns.
When you walk into a smoke shop today, you might notice the glass cases that once held rolling papers and blunt wraps now display CBD tinctures, functional mushroom capsules, kava elixirs, and hemp-infused sparkling water. The staff might talk to you about terpene profiles, cortisol levels, and a new vape line.
I went home and told my girlfriend, who, after Googling the name of the business I bought it from, told me that, yes, it was technically weed. But it was CBD. She started laughing, telling me I had been ripped off.